Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 2,202 | 299 | 1,878 |
| Samples | 998 | 171 | 814 |
| Peptides | 684 | 123 | 601 |
Function
NLRP8 · NLR family pyrin domain containing 8
This gene encodes a member of the nucleotide-binding oligomerization domain/ leucine rich repeat/ pyrin domain containing (NLRP) subfamily, which belongs to the Nod-like receptor family of proteins. NLRP genes play roles in the mammalian innate immune system through inflammasome formation and activation of caspases. In addition, NLRP genes have been found to function during mammalian reproduction. Consistent with a function during human preimplantation development, this gene is expressed at high levels in oocytes with decreased levels in embryos. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].
Isoforms & Proteins
2 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 673 amino-acid changes on canonical ENST00000291971 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in NLRP8 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in NLRP8 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Melanoma | 23/210 11% | 200/1899 11% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 7/133 5% |
| Endometrial Carcinoma | 4/42 10% | 30/612 5% |
| T-Lymphoblastic Leukemia | 2/40 5% | 0/0 0% |
| Non-Small Cell Lung Carcinoma | 28/304 9% | 56/1390 4% |
| Squamous Cell Lung Carcinoma | 6/57 11% | 35/810 4% |
| Other Solid Cancers | 2/94 2% | 73/1515 5% |
| Glioblastoma | 4/98 4% | 0/0 0% |
| Acute Myeloid Leukemia | 3/90 3% | 0/0 0% |
| Cervical Carcinoma | 4/35 11% | 11/422 3% |
| Small Cell Lung Carcinoma | 0/9 0% | 24/752 3% |
| Bladder Carcinoma | 4/58 7% | 26/956 3% |
| Colorectal Carcinoma | 13/143 9% | 84/3239 3% |
| Gastric Carcinoma | 3/74 4% | 46/1809 3% |
| Thymic Epithelial Tumor | 0/0 0% | 1/39 3% |
| Other Sarcomas | 9/69 13% | 10/699 1% |
| Head and Neck Carcinoma | 9/85 11% | 25/1574 2% |
| Neuroendocrine Tumour | 10/154 6% | 4/577 1% |
| Oral Cavity Carcinoma | 1/54 2% | 0/0 0% |
| Ewings Sarcoma | 6/63 10% | 0/262 0% |
| Esophageal Carcinoma | 0/23 0% | 12/769 2% |
| Hodgkins Lymphoma | 2/16 12% | 0/122 0% |
| Osteosarcoma | 2/45 4% | 1/166 1% |
| Pancreatic Carcinoma | 2/89 2% | 22/1611 1% |
| Chondrosarcoma | 0/14 0% | 1/75 1% |
| Germ Cell Tumour | 0/25 0% | 2/169 1% |
| Ovarian Carcinoma | 3/109 3% | 8/998 1% |
| Glioma | 1/52 2% | 20/2127 1% |
| Hepatocellular Carcinoma | 1/46 2% | 19/2210 1% |
| Adrenocortical Carcinoma | 0/3 0% | 1/112 1% |
Mutation Distribution
Where NLRP8 is mutated · all tissues, split by cell line vs tissue
How many mutations in NLRP8 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 7 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 2,202 mutations in NLRP8
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|